help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0754
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/10/5896    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maser, R. E.
Right arrow Articles by Lenhard, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maser, R. E.
Right arrow Articles by Lenhard, M. J.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 10 5896-5903
Copyright © 2005 by The Endocrine Society


REVIEW

Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and Treatment

Raelene E. Maser and M. James Lenhard

Department of Medical Technology (R.E.M.), University of Delaware, Newark, Delaware 19716; Diabetes and Metabolic Research Center (R.E.M., M.J.L.), Research Institute, Christiana Care Health Services, Newark, Delaware 19713; and Diabetes and Metabolic Diseases Center (M.J.L.), Christiana Care Health Services, Wilmington, Delaware 19801

Address all correspondence and requests for reprints to: Raelene E. Maser, Ph.D., Department of Medical Technology, 305F Willard Hall Education Building, University of Delaware, Newark, Delaware 19716. E-mail: rmaser{at}UDEL.EDU.

Context: The aim of this article was to review the importance of the clinical identification of persons with cardiovascular autonomic neuropathy (CAN) and discuss potential treatment interventions.

Evidence Acquisition: A MEDLINE search was conducted for articles published during the last 20 yr. In addition, subsequent references of retrieved articles were reviewed. Search strategies included using key terms such as CAN, heart rate variability, orthostatic hypotension, and diabetes mellitus.

Evidence Synthesis: CAN is a common form of diabetic autonomic neuropathy and causes abnormalities in heart rate control as well as central and peripheral vascular dynamics. The clinical manifestations of CAN include exercise intolerance, intraoperative cardiovascular lability, orthostatic hypotension, painless myocardial ischemia, and increased risk of mortality. CAN contributes to morbidity, mortality, and reduced quality of life for persons with diabetes. The American Diabetes Association has recently published a statement that provides guidelines for prevention, detection, and management of neuropathy, including CAN, for healthcare providers who care for patients with diabetes. Algorithms for the evaluation and treatment of the patient with CAN, even if the patient is asymptomatic, are provided in this review.

Conclusions: Once CAN is identified in a patient with diabetes, healthcare providers may consider altering the prescribed exercise regimen, increasing surveillance for cardiac ischemia, carefully reexamining the list of prescribed medications, and aggressively treating cardiovascular risk factors (e.g. hypertension) that may be associated with the development of CAN.




This article has been cited by other articles:


Home page
Diabetes CareHome page
S.-H. Ko, S.-A. Park, J.-H. Cho, K.-H. Song, K.-H. Yoon, B.-Y. Cha, H.-Y. Son, K.-D. Yoo, K.-W. Moon, Y.-M. Park, et al.
Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes: A 7-year follow-up study
Diabetes Care, September 1, 2008; 31(9): 1832 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al.
Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care
Diabetes Care, May 1, 2008; 31(5): 1060 - 1079.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J M Pappachan, J Sebastian, B C Bino, K Jayaprakash, K Vijayakumar, P Sujathan, and L A Adinegara
Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis
Postgrad. Med. J., April 1, 2008; 84(990): 205 - 210.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. L. Ducla-Soares, M. Santos-Bento, S. Laranjo, A. Andrade, E. Ducla-Soares, J. P. Boto, L. Silva-Carvalho, and I. Rocha
Wavelet analysis of autonomic outflow of normal subjects on head-up tilt, cold pressor test, Valsalva manoeuvre and deep breathing
Exp Physiol, July 1, 2007; 92(4): 677 - 686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society